Evaluation of Neuroprotective Effect of Minocycline

NCT01297816 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

OTHER

Sponsor class

Conditions

Retinal Detachment

Interventions

DRUG: placebo
DRUG: Minocycline

Sponsor

Shahid Beheshti University of Medical Sciences